Expert Witness Intake Form


A personality score can change from baseline in one treatment group. Establishing that the change differs from another treatment requires a direct comparison. Weiss and colleagues examined that distinction in an analysis of a randomized depression trial. What the researchers measured The investigators compared two treatment groups, one assigned to…
Read Article: Did Personality Scores Change Differently With Psilocybin Therapy and Escitalopram?
A decision model can show which assumptions most affect estimated costs. McCrone and colleagues used such a model to compare psilocybin-assisted therapy with medication, cognitive behavioral therapy, and their combination for severe depression. What the model projected The model simulated response, remission, and relapse over six months using inputs from…
Read Article: Which Assumptions Drove a Psilocybin Cost-Effectiveness Model?
Psilocybin-assisted therapy trials can combine the drug with different forms of psychological support. Chen and colleagues asked whether the support protocol was associated with differences in depressive symptoms across studies. What the review compared The analysis included 10 eligible studies with 515 adults. The authors classified the protocols by whether…